XOMA Royalty (XOMA) Short-term Investments (2012 - 2026)

XOMA Royalty's (XOMA) quarterly Short-term Investments came in at $500000.0 in Q1 2026, down 64.54% year-on-year from $1.4 million in Q1 2025, and down 90.81% quarter-over-quarter from $5.4 million in Q4 2025.

XOMA Royalty (XOMA) Short-term Investments (2012 - 2026) Analysis & Trends

XOMA Royalty has disclosed Short-term Investments across 12 years of filings, most recently posting $500000.0 for Q1 2026.

  • Short-term Investments for Q1 2026 came in at $500000.0, down 64.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $500000.0 (down 64.54% YoY), and the FY2025 annual result was $5.4 million, up 309.1% from the prior year.
  • Short-term Investments came in at $500000.0 for Q1 2026 at XOMA Royalty, down from $5.4 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $45.3 million in Q3 2025 to a low of $160000.0 in Q4 2023.
  • The 5-year median for Short-term Investments is $523000.0 (2022), against an average of $4.0 million.
  • Across the five-year window, Short-term Investments slumped 87.04% in 2022 and jumped 5669.17% in 2025, its largest moves.
  • XOMA Royalty's Short-term Investments stood at $335000.0 in 2022, then tumbled by 52.24% to $160000.0 in 2023, then soared by 731.25% to $1.3 million in 2024, then surged by 309.1% to $5.4 million in 2025, then sank by 90.81% to $500000.0 in 2026.
  • The last three Short-term Investments figures came in at $500000.0 (Q1 2026), $5.4 million (Q4 2025), and $45.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 XOMA Royalty 5.52 Mn -60.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Dec 31, 2025 5.44 Mn
Sep 30, 2025 45.29 Mn
Jun 30, 2025 8.80 Mn
Mar 31, 2025 1.41 Mn
Dec 31, 2024 1.33 Mn
Sep 30, 2024 785,000.00
Jun 30, 2024 696,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 160,000.00
Sep 30, 2023 214,000.00
Jun 30, 2023 320,000.00
Mar 31, 2023 311,000.00
Dec 31, 2022 335,000.00
Sep 30, 2022 443,000.00
Jun 30, 2022 523,000.00
Mar 31, 2022 800,000.00
Dec 31, 2021 774,000.00
Sep 30, 2021 3.42 Mn
Jun 30, 2021 2.31 Mn